Table 1.

Patient baseline characteristics

Demographic	BAK-free travoprost (n=199)
Mean age (±SD) (years)	66.6 (11.7)
Sex, n (%)
Female	117 (58.8)
Male	82 (41.2)
Treatment at baseline, n (%)
Latanoprost	156 (78.4)
Bimatoprost	43 (21.6)

Abbreviations: BAK, benzalkonium chloride; SD, standard deviation.